Daniel R. Schimmel, MD, explains how balloon pulmonary angioplasty (BPA) uses balloons and specialized catheters to open narrowed vessels in the lungs to improve circulation and reduce symptoms…
Nick Norwitz interviews Aseem Malhotra, MD, a consultant cardiologist, on controversial new findings challenging LDL cholesterol’s role as an independent risk factor for heart disease. They discuss data…
NEW YORK (Reuters Health) – Adults with subclinical hypothyroidism are at increased risk for heart failure and for changes in cardiac function, new research suggests. Subclinical hyperthyroidism, by…
NEW YORK (Reuters Health) – The results of a randomized trial suggest that statins may be a useful treatment for Raynaud’s phenomenon and digital ulcers that can accompany…
NEW YORK (Reuters Health) – Patients who quit smoking after undergoing coronary artery bypass graft (CABG) surgery can expect to live 3 years longer than patients who continue…
NEW YORK (Reuters Health) – Beta-adrenergic receptor antagonists are no more effective than other medications used for primary prevention of heart failure in patients with hypertension, according to…
NEW YORK (Reuters Health) – In hypertensive patients with a prior MI, a treatment strategy based on sustained release verapamil is comparable to one based on atenolol in…
NEW YORK (Reuters Health) – Exposure to bisphenol A (BPA), a chemical used in the resins that line food and beverage containers and in the production of polycarbonate…
NEW YORK (Reuters Health) – Findings from a new study suggest that contrary to what some researchers have hypothesized, migraine is not associated with atherosclerosis, but it may…
NEW YORK (Reuters Health) – In elderly patients with rheumatoid arthritis, treatment with tumor necrosis factor (TNF)-alpha antagonists may increase their risk of new-onset heart failure, and exacerbate…
NEW YORK (Reuters Health) – In patients with diabetes and coronary heart disease, an impaired antiplatelet response to low-dose aspirin can be overcome by increasing the aspirin dose…
NEW YORK (Reuters Health) – The results of a new study suggest that patients receiving long-term warfarin therapy do not need to stop the drug prior to coronary…